These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 21254921)

  • 1. Qualitative spectral OCT/SLO analysis of drusen change in dry age-related macular degeneration patients treated with Copaxone.
    Landa G; Rosen RB; Patel A; Lima VC; Tai KW; Perez VR; Aizman A; Garcia PM
    J Ocul Pharmacol Ther; 2011 Feb; 27(1):77-82. PubMed ID: 21254921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drusen characteristics revealed by spectral-domain optical coherence tomography and their corresponding fundus autofluorescence appearance in dry age-related macular degeneration.
    Landa G; Rosen RB; Pilavas J; Garcia PM
    Ophthalmic Res; 2012; 47(2):81-6. PubMed ID: 21757965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of Drusen Characteristics in Age-Related Macular Degeneration by Polarization-Sensitive Optical Coherence Tomography.
    Schlanitz FG; Sacu S; Baumann B; Bolz M; Platzer M; Pircher M; Hitzenberger CK; Schmidt-Erfurth U
    Am J Ophthalmol; 2015 Aug; 160(2):335-344.e1. PubMed ID: 25982973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drusen Volume and Retinal Pigment Epithelium Abnormal Thinning Volume Predict 2-Year Progression of Age-Related Macular Degeneration.
    Folgar FA; Yuan EL; Sevilla MB; Chiu SJ; Farsiu S; Chew EY; Toth CA;
    Ophthalmology; 2016 Jan; 123(1):39-50.e1. PubMed ID: 26578448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Weekly vaccination with Copaxone (glatiramer acetate) as a potential therapy for dry age-related macular degeneration.
    Landa G; Butovsky O; Shoshani J; Schwartz M; Pollack A
    Curr Eye Res; 2008 Nov; 33(11):1011-3. PubMed ID: 19085384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drusen ultrastructure imaging with spectral domain optical coherence tomography in age-related macular degeneration.
    Khanifar AA; Koreishi AF; Izatt JA; Toth CA
    Ophthalmology; 2008 Nov; 115(11):1883-90. PubMed ID: 18722666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spectral-domain optical coherence tomography characteristics of intermediate age-related macular degeneration.
    Leuschen JN; Schuman SG; Winter KP; McCall MN; Wong WT; Chew EY; Hwang T; Srivastava S; Sarin N; Clemons T; Harrington M; Toth CA
    Ophthalmology; 2013 Jan; 120(1):140-50. PubMed ID: 22968145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Photoreceptor layer thinning over drusen in eyes with age-related macular degeneration imaged in vivo with spectral-domain optical coherence tomography.
    Schuman SG; Koreishi AF; Farsiu S; Jung SH; Izatt JA; Toth CA
    Ophthalmology; 2009 Mar; 116(3):488-496.e2. PubMed ID: 19167082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optical coherence tomography-defined changes preceding the development of drusen-associated atrophy in age-related macular degeneration.
    Wu Z; Luu CD; Ayton LN; Goh JK; Lucci LM; Hubbard WC; Hageman JL; Hageman GS; Guymer RH
    Ophthalmology; 2014 Dec; 121(12):2415-22. PubMed ID: 25109931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and significance of subretinal drusenoid deposits (reticular pseudodrusen) in age-related macular degeneration.
    Zweifel SA; Imamura Y; Spaide TC; Fujiwara T; Spaide RF
    Ophthalmology; 2010 Sep; 117(9):1775-81. PubMed ID: 20472293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optical coherence tomography-based measurement of drusen load predicts development of advanced age-related macular degeneration.
    Nathoo NA; Or C; Young M; Chui L; Fallah N; Kirker AW; Albiani DA; Merkur AB; Forooghian F
    Am J Ophthalmol; 2014 Oct; 158(4):757-761.e1. PubMed ID: 24983793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined confocal scanning laser ophthalmoscopy and spectral-domain optical coherence tomography imaging of reticular drusen associated with age-related macular degeneration.
    Schmitz-Valckenberg S; Steinberg JS; Fleckenstein M; Visvalingam S; Brinkmann CK; Holz FG
    Ophthalmology; 2010 Jun; 117(6):1169-76. PubMed ID: 20163861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Automated assessment of drusen using three-dimensional spectral-domain optical coherence tomography.
    Iwama D; Hangai M; Ooto S; Sakamoto A; Nakanishi H; Fujimura T; Domalpally A; Danis RP; Yoshimura N
    Invest Ophthalmol Vis Sci; 2012 Mar; 53(3):1576-83. PubMed ID: 22297491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spectral domain optical coherence tomography imaging of drusen in nonexudative age-related macular degeneration.
    Gregori G; Wang F; Rosenfeld PJ; Yehoshua Z; Gregori NZ; Lujan BJ; Puliafito CA; Feuer WJ
    Ophthalmology; 2011 Jul; 118(7):1373-9. PubMed ID: 21388687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural history of drusen morphology in age-related macular degeneration using spectral domain optical coherence tomography.
    Yehoshua Z; Wang F; Rosenfeld PJ; Penha FM; Feuer WJ; Gregori G
    Ophthalmology; 2011 Dec; 118(12):2434-41. PubMed ID: 21724264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optical coherence tomography-raster scanning and manual segmentation in determining drusen volume in age-related macular degeneration.
    Freeman SR; Kozak I; Cheng L; Bartsch DU; Mojana F; Nigam N; Brar M; Yuson R; Freeman WR
    Retina; 2010 Mar; 30(3):431-5. PubMed ID: 19952989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Age-related macular degeneration and risk factors for the development of choroidal neovascularisation in the fellow eye: a 3-year follow-up study.
    Silva R; Cachulo ML; Fonseca P; Bernardes R; Nunes S; Vilhena N; Faria de Abreu JR
    Ophthalmologica; 2011; 226(3):110-8. PubMed ID: 21822000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of vitrectomy on the progression of dry age-related macular degeneration.
    Muftuoglu IK; Lin T; Bartsch DU; Freeman WR
    Graefes Arch Clin Exp Ophthalmol; 2021 Apr; 259(4):847-853. PubMed ID: 33064198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drusen ooze: Predictor for progression of dry age-related macular degeneration.
    Jhingan M; Singh SR; Samanta A; Arora S; Tucci D; Amarasekera S; Cagini C; Lupidi M; Chhablani J
    Graefes Arch Clin Exp Ophthalmol; 2021 Sep; 259(9):2687-2694. PubMed ID: 33710471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accuracy and reproducibility of automated drusen segmentation in eyes with non-neovascular age-related macular degeneration.
    Nittala MG; Ruiz-Garcia H; Sadda SR
    Invest Ophthalmol Vis Sci; 2012 Dec; 53(13):8319-24. PubMed ID: 23150629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.